Matrix degradation by chondrocytes cultured in alginate: IL-1β induces proteoglycan degradation and proMMP synthesis but does not result in collagen degradation

Osteoarthritis and Cartilage

Volumn 6, Issue 5, 1998, Pages 330-340

  Beekman, Bob ^a   Verzijl, Nicole ^a   De Roos, Jeroen A D M ^a   TeKoppele, Johan M ^a  

^a TNO   (Netherlands)

Author keywords

Chondrocytes; Interleukin 1; Matrix degradation; Matrix metalloproteinases

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; COLLAGEN; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; METALLOPROTEINASE; PROTEOGLYCAN;

ARTICLE; CARTILAGE CELL; DEGRADATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; PRIORITY JOURNAL;

EID: 0032170457     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1998.0132     Document Type: Article

References (68)

1. 1. Dayer J-M, Demczuk S. Cytokines and other mediators in rheumatoid arthritis. Springer Semin Immunopathol 1987;7:387-413.
2. 2. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-315.
3. 3. Goldring MB. Degradation of articular cartilage in culture: regulatory factors. In: Woessner JF, Howell DS, Eds. Joint Cartilage Degradation: Basic and Clinical Aspects. New York: Marcel Dekker Inc, 1992:281-345.
4. 4. Poole AR. Cellular biology of cartilage degradation. In: Henderson B, Edwards J, Pettipher R, Eds. Mechanisms and models in rheumatoid arthritis. London: Academic Press, 1995:171-212.
5. 5. Olliviere F, Gubler U, Towle CA, Laurencin, C, Treadwell BV. Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation. Biochem Biophys Res Commun 1986;141:904-911.
6. 6. Ahrend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-160.
7. 7. Gowen M, Wood DD, Ihrie EJ, Meats JE, Russell RGG. Stimulation by interleukin-1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoclasts in vitro. Biochim Biophys Acta 1984;797:186-193.
8. 8. Cawston TE. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 1996;70:163-182.
9. 9. Murphy G, Knäuper V. Relating matrix metalloproteinase structure to function: why the hemopexin domain. Matrix Biol 1997;15:511-518.
10. 10. Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992;267:3581-3584.
11. 11. Suzuki K, Enghild JJ, Morodori T, Salvesen G, Nagase H. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochem 1990;29:10261-10270.
12. 12. Knäuper V, López-Otín C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-1550.
13. 13. Knäuper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A, Tschesche H. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 1993;295:581-586.
14. 14. Fosang AJ, Neame PJ, Hardingham TE, Murphy G, Hamilton JA. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysin. J Biol Chem 1991;266:15579-15582.
15. 15. Hasty KA, Reife RA, Kang AH, Stuart JM. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990;33:388-397.
16. 16. Hughes CE, Caterson B, Fosang AJ, Roughly PJ, Mort JS. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J 1995;305:799-804.
17. 17. Sandy JD, Neame PJ, Boynton RE, Flannery CR. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem 1991;266:8683-8685.
18. 18. Flannery CR, Lark MW, Sandy JD. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. J Biol Chem 1992;267:1008-1014.
19. 374 in the interglobular domain of cartilage aggrecan. Biochem J 1994;304:347-351.
20. 20. Kozaci LD, Buttle DJ, Hollander AP. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum 1996;40:164-174.
21. 21. Rayan V, Hardingham T. The recovery of articular cartilage in explant culture from interleukin-1α: effects on proteoglycan synthesis and degradation. Matrix Biol 1994;14:263-271.
22. 22. Ilic M, Handly CJ, Robinson HC, Mok MT. Mechanisms of catabolism of aggrecan by articular cartilage. Archiv Biochem Biophys 1992;294:115-122.
23. 23. Mitchell PG, Lopresti-Morow L, Yocum SA, Sweeney FJ, Reiter LA. Inhibition of interleukin-1 stimulated collagen degradation in cartilage explants. Ann NY Acad Sci 1994;732:395-397.
24. 24. Ellis AJ, Curry VA, Powell EK, Cawston TE. The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight inhibitor. Biochem Biophys Res Commun 1994;201:94-101.
25. 25. Lefebvre V, Peeters-Joris C, Vaes G. Production of gelatin degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during dedifferention by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor α. Biochim Biophys Acta 1991;1094:8-18.
26. 26. Smith RJ, Justen JM, Ulrich RG, Lund JE, Sam LM. Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor α. Modulation of these cellular responses by interleukin-6 and plate-derived growth factor. Clin Immunol Immunopathol 1992;64:134-144.
27. 27. Stephenson ML, Goldring MB, Birkhead JR, Krane S, Rahmsdorf HJ, Angel P. Stimulation of procollagenase synthesis parallels increase in cellular procollagenase mRNA in human articluar chondrocytes exposed to recombinant interleukin 1β or phorbol ester. Biochem Biophys Res Commun 1987;144:583-590.
28. 28. Beekman B, Verzijl N, von der Mark K, TeKoppele JM. Synthesis of collagen by bovine chondrocytes cultured in alginate; post-translational modifications and cell-matrix interaction. Exp Cell Res 1997;237:135-141.
29. 29. Petit B, Masuda K, D'Souza AL, Otten L, Pietryla D, Hartman DJ, Morris NP, Uebelhart D, Schmid TM, Thonar EJ-MA. Characterization of crosslinked collagens synthesized by mature articular chondrocytes cultured in alginate beads: comparison of two distinct matrix components. Exp Cell Res 1996;225:151-161.
30. 30. Guo J, Jourdian GW, MacCallum DK. Culture and growth characteristics of chondrocytes encapsulated in alginate beads. Connect Tiss Res 1989;19:277-297.
31. 31. Häuselmann HJ, Aydelotte MB, Schumacher BL, Kuettner KE, Gitelis SH, Thonar EJ-MA. Synthesis and turnover of proteoglycans by human and bovine articular chondrocytes cultured in alginate. Matrix 1992;12:116-129.
32. 32. Kim YJ, Sah RL, Doong JY, Grodzinsky AJ. Fluorometric assay of DNA in cartilage expalnts using Hoechst 33258. Anal Biochem 1988;174:168-176.
33. 33. Monboisse V, Moinbosse JC, Borel JP, Randoux A. Nonisotopic evaluation of collagen in fibroblast cultures. Anal Biochem 1989;176:395-399.
34. 34. Bank RA, Krikken M, Beekman B, Stoop R, Maroudas A, Lafeber FPJG, TeKoppele JM. A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol 1997;16:233-243.
35. 35. Bank RA, Jansen EJ, Beekman B, TeKoppele, JM. Amino acid analysis by reverse phase high performance liquid chromatography: improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate. Anal Biochem 1996;240:167-176.
36. 36. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR. A synthetic metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993;53:2087-2091.
37. 37. Hanemaaijer R, Koolwijk P, Le Clercq L, de Vree WJA, van Hinsbergh VWM. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem J 1993;296:803-809.
38. 38. Beekman B, Drijhout JW, Bloemhoff W, Ronday HK, Tak PP, TeKoppele JM. Convenient fluorometric assay for matrix metaloproteinase activity and its application in biological media. FEBS Lett 1996;390:221-225.
39. 39. Cole AA, Chubinskaya S, Schumacher B, Huch K, Cs-Szabo G, Yao J, Mikecz K, Hasty K, Kuettner K. Chondrocyte matrix metalloproteinase 8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996;271:11023-11026.
40. 40. Woessner JF. Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 1995;248:510-528.
41. 41. Beekman B, Verzijl N, de Roos JADM, Koopman JL, TeKoppele JM. Doxycycline inhibitis collagen synthesis by bovine chondrocytes cultured in alginate. Biochem Biophys Res Commun 1997;237:107-110.
42. 42. Häuselmann HJ, Flechtenmacher J, Michal L, Thonar EJ-MA, Shinmei TM, Kuettner KE, Aydelotte MB. The superficial layer of human articular cartilage is more susceptible to IL-1 induced damage than the deeper layers. Arthritis Rheum 1996;39:478-488.
43. 43. Loulaki P, Shrikhande A, Davis G, Maniglia CA. N-Terminal sequence of proteoglycan fragments isolated from medium of interleukin-1 treated articular cartilage cultures. Biochem J 1992;284:589-593.
44. 44. Ratcliffe A, Tyler JA, Hardingham TE. Articular cartilage cultured with interleukin-1. Biochem J 1986;238:571-580.
45. 45. Cawston TE, Ellis AJ, Humm G, Lean E, Ward D, Curry V. Interleukin-1 and oncostatin M in combination promote the release of fragments from bovine nasal cartilage in culture. Biochem Biophys Res Commun 1995;215:377-385.
46. 46. Fosang AJ, Last K, Kn uper V, Neame PJ, Murphy G, Hardingham TE, Tschesche H, Hamilton JA. Fibroblast and neutrophil collagenase cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J 1993;295:273-276.
47. 47. Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G, Hamilton JA. The interglobular domain of cartilage aggrecan is cleaved by Pump, gelatinases and Cathepsin B. J Biol Chem 1992;267:19470-19474.
48. 48. Fosang AJ, Last K, Kn uper V, Murphy G, Hughes CE Neame PJ. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEbS Lett 1996;380:17-20.
49. 49. Nagase H, Ogata Y, Suzuki K, Enghild JJ, Salvesen G. Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem Soc Trans 1991;19:715-718.
50. 50. Arner EC, Decicco CP, Cherney R, Tortorella MD. Cleavage of native cartilage aggrecan by neutrophil collagenase is distinct from endogenous cleavage by aggrecanase. J Biol Chem 1997;272:9294-9299.
51. 51. Manicourt D-H, Lefebvre V. An assay for matrix metalloproteinases and other proteases acting on proteoglycans, casein, or gelatin. Anal Biochem 1993;215:171-179.
52. 52. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier J-M, Pelletier J-P. Excess of metalloproteinase over tissue inhibitor of metalloproteinases may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994;70:807-815.
53. 53. Crabbe T, Ioannou C, Docherty AJP. Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. Eur J Biochem 1993;218:431-438.
54. 54. Dodge GR, Poole AR. Immunohistochemical detection and immunohistochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 1989;83:647-661.
55. 55. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Poole AR. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-1732.
56. 56. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR. Enhanced cleavage of type II collagen by collagenases in osteoarthritic cartilage. J Clin Invest 1997;99:1534-1545.
57. 57. Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander S. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activities in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 1997;100:93-106.
58. 58. Singer IL, Kawka DW, Bayne EK, Donatelli SA, Weidner JR, Williams HR, Ayala JM, Mumford RA, Lark MW, Glant TT, Nabozny GH, David CS. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J Clin Invest 1995;95:2178-2186.
59. 59. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 1992;667:1-12.
60. 60. Gavrilovic J, Murphy G. The role of plasminogen in cell-mediated collagen degradation. Cell Biol Int Rep 1989, 13:367-375.
61. 61. Nagase H, Cawston TE, DeSilva M, Barrett AJ. Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid. Biochim Biophys Acta 1982;702:133-142.
62. 62. Lees M, Taylor DJ, Wooley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem 1994;223:171-177.
63. 63. Kummer AJ, Abbink JJ, De Boer JP, Roem D, Nieuwenhuys EJ, Kamp AM, Swaak TE, Hack CE. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and non-inflammatory joint diseases. Arthritis Rheum 1992;35:884-893.
64. 64. Suzuki M, Ito A, Mori Y, Hayashi Y, Matsuta K. Kallikrein in synovial fluid with rheumatoid arthritis. Biochem Med Metabol Biol 1987;37:177-183.
65. 65. Peppin GJ, Weiss SJ. Activivation of the endogenous metalloproteinase, gelatinase by triggered human neutrophils. Proc Natl Acad Sci USA 1986;83: 4322-4326.
66. 66. Capodici C, Berg RA. Neutrophil collagenase activation: the role of oxidants and cathepsin G. Agents Actions 1991;34:8-10.
67. 67. Gunja-Smith Z and Woesner JF. Activation of cartilage stromelysin-1 at acid pH and its relation to enzyme pH optimum and osteoathritis. Agents Actions 1993;40:228-231.
68. 68. Wilhelm SM, Shao ZH, Housley TJ, Separack PK, Baumann, AP, Gunja-Smith Z, Woessner JF. Matrix metalloproteinase-3 (stromelysin-1) Identification as the cartilage acid metalloproteinase and effect of pH on catalytic properties and calcium. J Biol Chem 1993;268:21906-21913.